Patanjali Ayurvedic Medicines has launched ‘Coronil’ anti-COVID tablets to combat and prevent the spread of the deadly coronavirus. Researched by Patanjali Research Institute with clinical trails held at NIMS University, Jaipur, the anti-corona tablet was launched by Baba Ramdev on Tuesday. Clinical control trials were carried out adhering to standardized protocols of drug discovery to evaluate its efficacy, the company said. Within the span of 3 to 15 days, all the corona positive patients transformed into negative ones without observing any mortality, the company’s release about the tablet claims.
Related Posts
India logs 48,786 new COVID-19 cases, recovery rate at 96.97%
India on Thursday recorded 48,786 new COVID-19 cases in the last 24 hours. Active cases are now below 8 lakh mark at 5,23,257. Active cases constitute 1.72% of total cases.In the last 24 hours, 61,588 patients recovered from the infection.…
New Covid-19 cases crosses 1,000 mark in Delhi, 2 Covid deaths in last 24 hours
The fresh Covid cases crossed the 1,000 mark in Delhi on Friday as a total of 1,042 new Covid-19 cases were recorded in the national capital out of 22442 tests conducted during the past 24 hours across the city. The…
ZEE donates Critical Healthcare Equipment
In line with its national level CSR drive against Covid-19, ZEE Entertainment Enterprises Limited (ZEE) handed over critical healthcare equipment (20 oxygen humidifiers) to the state of West Bengal in the presence of Mr Narayan Swaroop Nigam, Secretary, Health &…